Thiamin Fortified Fish Sauce as a Means of Combating Infantile Beriberi in Rural Cambodia

NCT02221063 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 366

Last updated 2016-05-25

No results posted yet for this study

Summary

The purpose of this study is to determine whether consumption of thiamin fortified fish sauce over 6 months increases the thiamin status of women to a level consistent with a low risk of infantile beriberi. The investigators hypothesize that consumption of thiamin-fortified fish sauce will increase red blood cell thiamin concentrations, an indicator of thiamin status, in women consuming thiamin-fortified fish sauce, while concentrations will not change in women consuming a placebo fish sauce that does not contain thiamin.

Conditions

  • Thiamin Deficiency

Interventions

OTHER

Thiamin fortified fish sauce (low concentration)

Low concentration thiamin fortified fish sauce will be consumed ad libitum for 6 months, with biweekly monitoring and evaluation to assess fish sauce usage by household and to re-stock fish sauce within the home.

OTHER

Thiamin fortified fish sauce (higher concentration)

Higher concentration thiamin fortified fish sauce will be consumed ad libitum for 6 months, with biweekly monitoring and evaluation to assess fish sauce usage by household and to re-stock fish sauce within the home.

OTHER

Placebo fish sauce

Fish sauce fortified only with iron, not thiamin, will be consumed ad libitum for 6 months, with biweekly monitoring and evaluation to assess fish sauce usage by household and to re-stock fish sauce within the home.

Sponsors & Collaborators

  • Helen Keller International

    collaborator OTHER
  • Grand Challenges Canada

    collaborator OTHER
  • International Development Research Centre, Canada

    collaborator OTHER_GOV
  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV
  • University of British Columbia

    lead OTHER

Principal Investigators

  • Tim J Green, PhD · University of British Columbia

  • Kyly C Whitfield, MSc · University of British Columbia

  • Judy McLean, PhD · University of British Columbia

  • Zaman Talukder, MPH · Helen Keller International

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-04-30
Completion
2016-04-30

Countries

  • Cambodia

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02221063 on ClinicalTrials.gov